nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—Cardiac flutter—Varenicline—nicotine dependence	0.0501	0.149	CcSEcCtD
Verapamil—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0158	0.0471	CcSEcCtD
Verapamil—Sleep disturbance—Varenicline—nicotine dependence	0.0147	0.0436	CcSEcCtD
Verapamil—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0125	0.0373	CcSEcCtD
Verapamil—Nystagmus—Varenicline—nicotine dependence	0.0115	0.0342	CcSEcCtD
Verapamil—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0109	0.0325	CcSEcCtD
Verapamil—CACNA1S—cardiovascular system—nicotine dependence	0.0107	0.0537	CbGeAlD
Verapamil—CACNB1—cardiovascular system—nicotine dependence	0.01	0.0501	CbGeAlD
Verapamil—CACNB4—midbrain—nicotine dependence	0.00978	0.049	CbGeAlD
Verapamil—Accidental injury—Varenicline—nicotine dependence	0.00928	0.0276	CcSEcCtD
Verapamil—CACNA1B—midbrain—nicotine dependence	0.00911	0.0456	CbGeAlD
Verapamil—CACNB1—midbrain—nicotine dependence	0.00781	0.0391	CbGeAlD
Verapamil—CACNB3—midbrain—nicotine dependence	0.00749	0.0375	CbGeAlD
Verapamil—CACNA1I—brain—nicotine dependence	0.00747	0.0374	CbGeAlD
Verapamil—Sleep disorder—Varenicline—nicotine dependence	0.00689	0.0205	CcSEcCtD
Verapamil—CACNA1H—cardiovascular system—nicotine dependence	0.00682	0.0342	CbGeAlD
Verapamil—Injury—Varenicline—nicotine dependence	0.00649	0.0193	CcSEcCtD
Verapamil—CACNB2—cardiovascular system—nicotine dependence	0.00644	0.0323	CbGeAlD
Verapamil—CACNB4—brain—nicotine dependence	0.00614	0.0308	CbGeAlD
Verapamil—KCNJ11—cardiovascular system—nicotine dependence	0.00611	0.0306	CbGeAlD
Verapamil—Cerebrovascular accident—Varenicline—nicotine dependence	0.00609	0.0181	CcSEcCtD
Verapamil—Lethargy—Varenicline—nicotine dependence	0.00609	0.0181	CcSEcCtD
Verapamil—CACNA1A—brain—nicotine dependence	0.00587	0.0294	CbGeAlD
Verapamil—Psychotic disorder—Varenicline—nicotine dependence	0.00582	0.0173	CcSEcCtD
Verapamil—CACNA1B—brain—nicotine dependence	0.00572	0.0287	CbGeAlD
Verapamil—CACNA1D—cardiovascular system—nicotine dependence	0.00563	0.0282	CbGeAlD
Verapamil—Cramp muscle—Varenicline—nicotine dependence	0.00537	0.016	CcSEcCtD
Verapamil—CACNA1C—cardiovascular system—nicotine dependence	0.0052	0.026	CbGeAlD
Verapamil—CACNA1G—brain—nicotine dependence	0.00512	0.0256	CbGeAlD
Verapamil—SCN5A—cardiovascular system—nicotine dependence	0.00504	0.0252	CbGeAlD
Verapamil—Angina pectoris—Varenicline—nicotine dependence	0.00502	0.0149	CcSEcCtD
Verapamil—Abdominal discomfort—Varenicline—nicotine dependence	0.00494	0.0147	CcSEcCtD
Verapamil—CACNB1—brain—nicotine dependence	0.00491	0.0246	CbGeAlD
Verapamil—Pollakiuria—Varenicline—nicotine dependence	0.00476	0.0142	CcSEcCtD
Verapamil—Erectile dysfunction—Varenicline—nicotine dependence	0.00475	0.0141	CcSEcCtD
Verapamil—CACNB3—brain—nicotine dependence	0.00471	0.0236	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00456	0.0136	CcSEcCtD
Verapamil—Acute coronary syndrome—Varenicline—nicotine dependence	0.00453	0.0135	CcSEcCtD
Verapamil—Myocardial infarction—Varenicline—nicotine dependence	0.0045	0.0134	CcSEcCtD
Verapamil—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00444	0.00956	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00444	0.00956	CbGpPWpGaD
Verapamil—Sinusitis—Varenicline—nicotine dependence	0.00431	0.0128	CcSEcCtD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00421	0.00906	CbGpPWpGaD
Verapamil—Bradycardia—Varenicline—nicotine dependence	0.0042	0.0125	CcSEcCtD
Verapamil—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00413	0.0089	CbGpPWpGaD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00413	0.00889	CbGpPWpGaD
Verapamil—Hypoaesthesia—Varenicline—nicotine dependence	0.0041	0.0122	CcSEcCtD
Verapamil—Oedema peripheral—Varenicline—nicotine dependence	0.00406	0.0121	CcSEcCtD
Verapamil—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.004	0.00862	CbGpPWpGaD
Verapamil—Visual impairment—Varenicline—nicotine dependence	0.00398	0.0118	CcSEcCtD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00391	0.00842	CbGpPWpGaD
Verapamil—Erythema multiforme—Varenicline—nicotine dependence	0.0039	0.0116	CcSEcCtD
Verapamil—Tinnitus—Varenicline—nicotine dependence	0.00385	0.0115	CcSEcCtD
Verapamil—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00368	0.00793	CbGpPWpGaD
Verapamil—ABCC10—midbrain—nicotine dependence	0.00367	0.0184	CbGeAlD
Verapamil—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00365	0.00786	CbGpPWpGaD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00351	0.00756	CbGpPWpGaD
Verapamil—Muscle spasms—Varenicline—nicotine dependence	0.00345	0.0103	CcSEcCtD
Verapamil—CACNA1B—Neuronal System—CHRNB3—nicotine dependence	0.0034	0.00732	CbGpPWpGaD
Verapamil—Vision blurred—Varenicline—nicotine dependence	0.00338	0.0101	CcSEcCtD
Verapamil—Tremor—Varenicline—nicotine dependence	0.00336	0.01	CcSEcCtD
Verapamil—CACNA1H—brain—nicotine dependence	0.00335	0.0168	CbGeAlD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00333	0.00716	CbGpPWpGaD
Verapamil—Agitation—Varenicline—nicotine dependence	0.0033	0.00983	CcSEcCtD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0033	0.0071	CbGpPWpGaD
Verapamil—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00328	0.00707	CbGpPWpGaD
Verapamil—Angioedema—Varenicline—nicotine dependence	0.00328	0.00977	CcSEcCtD
Verapamil—Vertigo—Varenicline—nicotine dependence	0.00323	0.00961	CcSEcCtD
Verapamil—CACNA1B—Neuronal System—CHRNA6—nicotine dependence	0.00322	0.00694	CbGpPWpGaD
Verapamil—Syncope—Varenicline—nicotine dependence	0.00322	0.00959	CcSEcCtD
Verapamil—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00321	0.00691	CbGpPWpGaD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00321	0.00691	CbGpPWpGaD
Verapamil—Palpitations—Varenicline—nicotine dependence	0.00317	0.00945	CcSEcCtD
Verapamil—SLCO1A2—midbrain—nicotine dependence	0.00317	0.0159	CbGeAlD
Verapamil—CACNB4—Neuronal System—CHRNB3—nicotine dependence	0.00316	0.00681	CbGpPWpGaD
Verapamil—CACNB2—brain—nicotine dependence	0.00316	0.0158	CbGeAlD
Verapamil—Loss of consciousness—Varenicline—nicotine dependence	0.00316	0.0094	CcSEcCtD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00313	0.00673	CbGpPWpGaD
Verapamil—Convulsion—Varenicline—nicotine dependence	0.00311	0.00926	CcSEcCtD
Verapamil—Hypertension—Varenicline—nicotine dependence	0.0031	0.00923	CcSEcCtD
Verapamil—KCNH2—cardiovascular system—nicotine dependence	0.0031	0.0155	CbGeAlD
Verapamil—SLC6A4—midbrain—nicotine dependence	0.00306	0.0153	CbGeAlD
Verapamil—Arthralgia—Varenicline—nicotine dependence	0.00306	0.0091	CcSEcCtD
Verapamil—Myalgia—Varenicline—nicotine dependence	0.00306	0.0091	CcSEcCtD
Verapamil—Chest pain—Varenicline—nicotine dependence	0.00306	0.0091	CcSEcCtD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00304	0.00655	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00304	0.00655	CbGpPWpGaD
Verapamil—Discomfort—Varenicline—nicotine dependence	0.00302	0.00899	CcSEcCtD
Verapamil—KCNJ11—brain—nicotine dependence	0.003	0.015	CbGeAlD
Verapamil—CACNB4—Neuronal System—CHRNA6—nicotine dependence	0.003	0.00645	CbGpPWpGaD
Verapamil—Dry mouth—Varenicline—nicotine dependence	0.00299	0.0089	CcSEcCtD
Verapamil—Oedema—Varenicline—nicotine dependence	0.00293	0.00873	CcSEcCtD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00292	0.00628	CbGpPWpGaD
Verapamil—Infection—Varenicline—nicotine dependence	0.00291	0.00867	CcSEcCtD
Verapamil—Shock—Varenicline—nicotine dependence	0.00288	0.00858	CcSEcCtD
Verapamil—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00287	0.00619	CbGpPWpGaD
Verapamil—Tachycardia—Varenicline—nicotine dependence	0.00286	0.00852	CcSEcCtD
Verapamil—Hyperhidrosis—Varenicline—nicotine dependence	0.00283	0.00844	CcSEcCtD
Verapamil—CACNB4—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00283	0.00609	CbGpPWpGaD
Verapamil—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00278	0.00599	CbGpPWpGaD
Verapamil—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00277	0.00597	CbGpPWpGaD
Verapamil—CACNA1D—brain—nicotine dependence	0.00276	0.0138	CbGeAlD
Verapamil—Hypotension—Varenicline—nicotine dependence	0.00274	0.00815	CcSEcCtD
Verapamil—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00274	0.00589	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00271	0.00584	CbGpPWpGaD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00271	0.00584	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNB3—nicotine dependence	0.00269	0.00579	CbGpPWpGaD
Verapamil—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00267	0.00795	CcSEcCtD
Verapamil—Insomnia—Varenicline—nicotine dependence	0.00265	0.00789	CcSEcCtD
Verapamil—Dyspnoea—Varenicline—nicotine dependence	0.00261	0.00778	CcSEcCtD
Verapamil—Somnolence—Varenicline—nicotine dependence	0.00261	0.00776	CcSEcCtD
Verapamil—Dyspepsia—Varenicline—nicotine dependence	0.00258	0.00768	CcSEcCtD
Verapamil—CACNA1C—brain—nicotine dependence	0.00255	0.0128	CbGeAlD
Verapamil—CACNA1A—Neuronal System—CHRNA6—nicotine dependence	0.00255	0.00549	CbGpPWpGaD
Verapamil—CYP2B6—cardiovascular system—nicotine dependence	0.00254	0.0127	CbGeAlD
Verapamil—CACNB3—Neuronal System—CHRNB3—nicotine dependence	0.00253	0.00544	CbGpPWpGaD
Verapamil—Fatigue—Varenicline—nicotine dependence	0.00253	0.00752	CcSEcCtD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00252	0.00543	CbGpPWpGaD
Verapamil—CYP2C9—cardiovascular system—nicotine dependence	0.00252	0.0126	CbGeAlD
Verapamil—Constipation—Varenicline—nicotine dependence	0.00251	0.00746	CcSEcCtD
Verapamil—Pain—Varenicline—nicotine dependence	0.00251	0.00746	CcSEcCtD
Verapamil—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00248	0.00534	CbGpPWpGaD
Verapamil—SCN5A—brain—nicotine dependence	0.00247	0.0124	CbGeAlD
Verapamil—CACNB1—Neuronal System—CHRNB3—nicotine dependence	0.00246	0.00529	CbGpPWpGaD
Verapamil—KCNH2—midbrain—nicotine dependence	0.00242	0.0121	CbGeAlD
Verapamil—Feeling abnormal—Varenicline—nicotine dependence	0.00242	0.00719	CcSEcCtD
Verapamil—CACNA1A—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00241	0.00518	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNA6—nicotine dependence	0.0024	0.00516	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—CHRNA6—nicotine dependence	0.00233	0.00502	CbGpPWpGaD
Verapamil—CACNA1B—Neuronal System—GABRA4—nicotine dependence	0.00233	0.00502	CbGpPWpGaD
Verapamil—Urticaria—Varenicline—nicotine dependence	0.00233	0.00693	CcSEcCtD
Verapamil—ABCC3—brain—nicotine dependence	0.00232	0.0116	CbGeAlD
Verapamil—ABCC10—brain—nicotine dependence	0.00231	0.0116	CbGeAlD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00231	0.00496	CbGpPWpGaD
Verapamil—SLC22A5—midbrain—nicotine dependence	0.00229	0.0115	CbGeAlD
Verapamil—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00228	0.00491	CbGpPWpGaD
Verapamil—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00226	0.00487	CbGpPWpGaD
Verapamil—CACNB3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00226	0.00487	CbGpPWpGaD
Verapamil—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00225	0.00484	CbGpPWpGaD
Verapamil—CACNA1B—Neuronal System—CHRNB4—nicotine dependence	0.00224	0.00481	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00221	0.00476	CbGpPWpGaD
Verapamil—CACNB1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0022	0.00474	CbGpPWpGaD
Verapamil—SLC22A4—brain—nicotine dependence	0.00217	0.0109	CbGeAlD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00217	0.00467	CbGpPWpGaD
Verapamil—CACNB4—Neuronal System—GABRA4—nicotine dependence	0.00217	0.00467	CbGpPWpGaD
Verapamil—Hypersensitivity—Varenicline—nicotine dependence	0.00216	0.00643	CcSEcCtD
Verapamil—ABCG2—midbrain—nicotine dependence	0.00215	0.0108	CbGeAlD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00214	0.00462	CbGpPWpGaD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00211	0.00454	CbGpPWpGaD
Verapamil—Asthenia—Varenicline—nicotine dependence	0.0021	0.00626	CcSEcCtD
Verapamil—CACNB4—Neuronal System—CHRNB4—nicotine dependence	0.00208	0.00447	CbGpPWpGaD
Verapamil—CACNA1B—Neuronal System—CHRNA5—nicotine dependence	0.00208	0.00447	CbGpPWpGaD
Verapamil—Pruritus—Varenicline—nicotine dependence	0.00207	0.00617	CcSEcCtD
Verapamil—SLC22A1—brain—nicotine dependence	0.00207	0.0104	CbGeAlD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00206	0.00442	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00202	0.00434	CbGpPWpGaD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00202	0.00434	CbGpPWpGaD
Verapamil—Diarrhoea—Varenicline—nicotine dependence	0.00201	0.00597	CcSEcCtD
Verapamil—SLCO1A2—brain—nicotine dependence	0.00199	0.00997	CbGeAlD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00196	0.00422	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00195	0.00419	CbGpPWpGaD
Verapamil—Dizziness—Varenicline—nicotine dependence	0.00194	0.00577	CcSEcCtD
Verapamil—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00193	0.00416	CbGpPWpGaD
Verapamil—CACNB4—Neuronal System—CHRNA5—nicotine dependence	0.00193	0.00416	CbGpPWpGaD
Verapamil—SLC6A4—brain—nicotine dependence	0.00192	0.00963	CbGeAlD
Verapamil—ABCC4—brain—nicotine dependence	0.00192	0.0096	CbGeAlD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00191	0.00411	CbGpPWpGaD
Verapamil—Vomiting—Varenicline—nicotine dependence	0.00186	0.00555	CcSEcCtD
Verapamil—Rash—Varenicline—nicotine dependence	0.00185	0.0055	CcSEcCtD
Verapamil—Dermatitis—Varenicline—nicotine dependence	0.00185	0.0055	CcSEcCtD
Verapamil—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00184	0.00397	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—GABRA4—nicotine dependence	0.00184	0.00397	CbGpPWpGaD
Verapamil—Headache—Varenicline—nicotine dependence	0.00184	0.00547	CcSEcCtD
Verapamil—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00182	0.00392	CbGpPWpGaD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00181	0.0039	CbGpPWpGaD
Verapamil—CACNA1B—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00177	0.0038	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNB4—nicotine dependence	0.00177	0.0038	CbGpPWpGaD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00175	0.00376	CbGpPWpGaD
Verapamil—Nausea—Varenicline—nicotine dependence	0.00174	0.00518	CcSEcCtD
Verapamil—CACNB3—Neuronal System—GABRA4—nicotine dependence	0.00173	0.00373	CbGpPWpGaD
Verapamil—CACNA1B—Neuronal System—CHRNA3—nicotine dependence	0.00169	0.00365	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—GABRA4—nicotine dependence	0.00169	0.00363	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNB4—nicotine dependence	0.00166	0.00358	CbGpPWpGaD
Verapamil—CACNB4—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00164	0.00354	CbGpPWpGaD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00164	0.00354	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNA5—nicotine dependence	0.00164	0.00354	CbGpPWpGaD
Verapamil—ABCC1—brain—nicotine dependence	0.00163	0.00818	CbGeAlD
Verapamil—CACNB1—Neuronal System—CHRNB4—nicotine dependence	0.00162	0.00348	CbGpPWpGaD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0016	0.00344	CbGpPWpGaD
Verapamil—CACNB4—Neuronal System—CHRNA3—nicotine dependence	0.00157	0.00339	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNB3—nicotine dependence	0.00154	0.00332	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNA5—nicotine dependence	0.00154	0.00332	CbGpPWpGaD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00154	0.00331	CbGpPWpGaD
Verapamil—KCNH2—brain—nicotine dependence	0.00152	0.00762	CbGeAlD
Verapamil—CACNB1—Neuronal System—CHRNA5—nicotine dependence	0.0015	0.00323	CbGpPWpGaD
Verapamil—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0015	0.00322	CbGpPWpGaD
Verapamil—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00149	0.00321	CbGpPWpGaD
Verapamil—CACNA1B—Neuronal System—CHRNB2—nicotine dependence	0.00149	0.00321	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNB3—nicotine dependence	0.00147	0.00317	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNA6—nicotine dependence	0.00146	0.00315	CbGpPWpGaD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00145	0.00311	CbGpPWpGaD
Verapamil—SLC22A5—brain—nicotine dependence	0.00144	0.0072	CbGeAlD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00141	0.00303	CbGpPWpGaD
Verapamil—CACNA1A—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0014	0.00301	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNA6—nicotine dependence	0.0014	0.00301	CbGpPWpGaD
Verapamil—CYP2C8—brain—nicotine dependence	0.00139	0.00697	CbGeAlD
Verapamil—CACNB4—Neuronal System—CHRNB2—nicotine dependence	0.00139	0.00298	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00138	0.00297	CbGpPWpGaD
Verapamil—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00136	0.00294	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00136	0.00293	CbGpPWpGaD
Verapamil—ABCB1—cardiovascular system—nicotine dependence	0.00136	0.00681	CbGeAlD
Verapamil—CACNA1B—Neuronal System—CHRNA4—nicotine dependence	0.00135	0.00292	CbGpPWpGaD
Verapamil—ABCG2—brain—nicotine dependence	0.00135	0.00678	CbGeAlD
Verapamil—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00135	0.0029	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNA3—nicotine dependence	0.00134	0.00288	CbGpPWpGaD
Verapamil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00133	0.00287	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00132	0.00285	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00132	0.00284	CbGpPWpGaD
Verapamil—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00132	0.00283	CbGpPWpGaD
Verapamil—CACNB3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00131	0.00283	CbGpPWpGaD
Verapamil—CACNB1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00128	0.00275	CbGpPWpGaD
Verapamil—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00127	0.00273	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00126	0.00271	CbGpPWpGaD
Verapamil—CACNB4—Neuronal System—CHRNA4—nicotine dependence	0.00126	0.00271	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNA3—nicotine dependence	0.00126	0.00271	CbGpPWpGaD
Verapamil—CYP2B6—brain—nicotine dependence	0.00125	0.00625	CbGeAlD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00123	0.00265	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—CHRNA3—nicotine dependence	0.00122	0.00264	CbGpPWpGaD
Verapamil—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00119	0.00257	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00119	0.00257	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00119	0.00255	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNB2—nicotine dependence	0.00118	0.00254	CbGpPWpGaD
Verapamil—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00118	0.00254	CbGpPWpGaD
Verapamil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00115	0.00249	CbGpPWpGaD
Verapamil—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00114	0.00245	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNB2—nicotine dependence	0.00111	0.00239	CbGpPWpGaD
Verapamil—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00111	0.00238	CbGpPWpGaD
Verapamil—ABCC10—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0011	0.00236	CbGpPWpGaD
Verapamil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00108	0.00233	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—CHRNB2—nicotine dependence	0.00108	0.00232	CbGpPWpGaD
Verapamil—CACNA1A—Neuronal System—CHRNA4—nicotine dependence	0.00107	0.0023	CbGpPWpGaD
Verapamil—ABCB1—midbrain—nicotine dependence	0.00106	0.00532	CbGeAlD
Verapamil—CACNB2—Neuronal System—GABRA4—nicotine dependence	0.00106	0.00228	CbGpPWpGaD
Verapamil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00103	0.00222	CbGpPWpGaD
Verapamil—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00102	0.00219	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNB4—nicotine dependence	0.00101	0.00218	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—GABRA4—nicotine dependence	0.00101	0.00217	CbGpPWpGaD
Verapamil—CACNB3—Neuronal System—CHRNA4—nicotine dependence	0.00101	0.00217	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.001	0.00216	CbGpPWpGaD
Verapamil—CACNB1—Neuronal System—CHRNA4—nicotine dependence	0.000979	0.00211	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNB4—nicotine dependence	0.000968	0.00208	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000956	0.00206	CbGpPWpGaD
Verapamil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000948	0.00204	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNA5—nicotine dependence	0.000943	0.00203	CbGpPWpGaD
Verapamil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00094	0.00202	CbGpPWpGaD
Verapamil—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000936	0.00202	CbGpPWpGaD
Verapamil—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000936	0.00201	CbGpPWpGaD
Verapamil—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000927	0.002	CbGpPWpGaD
Verapamil—CYP2D6—brain—nicotine dependence	0.000927	0.00464	CbGeAlD
Verapamil—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000907	0.00195	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000906	0.00195	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNA5—nicotine dependence	0.0009	0.00194	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000884	0.0019	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000879	0.00189	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.000863	0.00186	CbGpPWpGaD
Verapamil—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000843	0.00181	CbGpPWpGaD
Verapamil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000836	0.0018	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.000827	0.00178	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000823	0.00177	CbGpPWpGaD
Verapamil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000803	0.00173	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000802	0.00173	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000798	0.00172	CbGpPWpGaD
Verapamil—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.000794	0.00171	CbGpPWpGaD
Verapamil—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000793	0.00171	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000791	0.0017	CbGpPWpGaD
Verapamil—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000783	0.00169	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.000769	0.00166	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNA3—nicotine dependence	0.000769	0.00166	CbGpPWpGaD
Verapamil—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000769	0.00165	CbGpPWpGaD
Verapamil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000762	0.00164	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNA3—nicotine dependence	0.000734	0.00158	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.000732	0.00158	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000719	0.00155	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.000694	0.00149	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNB2—nicotine dependence	0.000677	0.00146	CbGpPWpGaD
Verapamil—ABCB1—brain—nicotine dependence	0.000667	0.00334	CbGeAlD
Verapamil—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000655	0.00141	CbGpPWpGaD
Verapamil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000651	0.0014	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000646	0.00139	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNB2—nicotine dependence	0.000646	0.00139	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000628	0.00135	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.000627	0.00135	CbGpPWpGaD
Verapamil—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000623	0.00134	CbGpPWpGaD
Verapamil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00062	0.00133	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—CHRNA4—nicotine dependence	0.000615	0.00132	CbGpPWpGaD
Verapamil—SLC22A4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000612	0.00132	CbGpPWpGaD
Verapamil—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000612	0.00132	CbGpPWpGaD
Verapamil—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000609	0.00131	CbGpPWpGaD
Verapamil—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000587	0.00126	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—CHRNA4—nicotine dependence	0.000587	0.00126	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000584	0.00126	CbGpPWpGaD
Verapamil—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000579	0.00125	CbGpPWpGaD
Verapamil—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000574	0.00124	CbGpPWpGaD
Verapamil—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000566	0.00122	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.000552	0.00119	CbGpPWpGaD
Verapamil—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000528	0.00114	CbGpPWpGaD
Verapamil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000502	0.00108	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.000502	0.00108	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.000501	0.00108	CbGpPWpGaD
Verapamil—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000497	0.00107	CbGpPWpGaD
Verapamil—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00049	0.00106	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.000481	0.00104	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.000478	0.00103	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000476	0.00102	CbGpPWpGaD
Verapamil—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000471	0.00101	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—CYP2A7—nicotine dependence	0.000464	0.000999	CbGpPWpGaD
Verapamil—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00046	0.000991	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.000447	0.000963	CbGpPWpGaD
Verapamil—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000444	0.000955	CbGpPWpGaD
Verapamil—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000438	0.000942	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—CYP2A7—nicotine dependence	0.000436	0.000939	CbGpPWpGaD
Verapamil—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000433	0.000932	CbGpPWpGaD
Verapamil—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000429	0.000924	CbGpPWpGaD
Verapamil—ABCC3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000424	0.000913	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000419	0.000902	CbGpPWpGaD
Verapamil—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000408	0.000879	CbGpPWpGaD
Verapamil—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000405	0.000871	CbGpPWpGaD
Verapamil—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000403	0.000867	CbGpPWpGaD
Verapamil—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000399	0.000859	CbGpPWpGaD
Verapamil—ABCC4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000399	0.000859	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000381	0.000819	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000369	0.000795	CbGpPWpGaD
Verapamil—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000367	0.00079	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000365	0.000785	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000346	0.000744	CbGpPWpGaD
Verapamil—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000341	0.000734	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000336	0.000724	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000332	0.000716	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000321	0.000691	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000316	0.00068	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000293	0.00063	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000292	0.000628	CbGpPWpGaD
Verapamil—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000283	0.00061	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00027	0.000581	CbGpPWpGaD
Verapamil—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000267	0.000575	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CYP2A7—nicotine dependence	0.000267	0.000574	CbGpPWpGaD
Verapamil—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000263	0.000567	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CYP2A7—nicotine dependence	0.000254	0.000547	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CYP2A7—nicotine dependence	0.000252	0.000543	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CYP2A7—nicotine dependence	0.000222	0.000477	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CYP2A7—nicotine dependence	0.000207	0.000446	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000204	0.00044	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKR1B10—nicotine dependence	0.0002	0.000431	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CYP2A7—nicotine dependence	0.000199	0.000428	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000173	0.000373	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000158	0.000341	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000335	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000148	0.000319	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000137	0.000295	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000136	0.000292	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000126	0.000272	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.0001	0.000216	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP2A7—nicotine dependence	9.82e-05	0.000211	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP2A7—nicotine dependence	8.5e-05	0.000183	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP2A7—nicotine dependence	7.59e-05	0.000163	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP2A7—nicotine dependence	7.41e-05	0.000159	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP2A7—nicotine dependence	6.98e-05	0.00015	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP2A7—nicotine dependence	6.92e-05	0.000149	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2A7—nicotine dependence	5.91e-05	0.000127	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.56e-05	9.83e-05	CbGpPWpGaD
